| Serial Number | 86834490 |
| Word Mark | AMGEN |
| Filing Date | Monday, November 30, 2015 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 16, 2020 |
| Registration Number | 6080333 |
| Registration Date | Tuesday, June 16, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 16, 2016 |
| Goods and Services | Educational services, namely, development and dissemination of printed educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting seminars in the field of the use of prescription pharmaceutical products for medical disorders; educational and entertainment services, namely, providing a motivational and educational speaker featuring information regarding medical disorders; training services in the field of patient support services relating to treatment of medical disorders; providing on-line electronic newsletters delivered by email in the field of the treatment of medical disorders |
| Goods and Services | Pharmaceuticals for the treatment of cardiovascular, cancer, bone, neurological nephrological and inflammation disease and disorders; pharmaceutical preparations for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; prescription pharmaceuticals for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith |
| Goods and Services | Providing healthcare administration, namely, providing insurance verification and prior authorization services for others |
| Goods and Services | Online wholesale services by direct solicitation by salespersons directed to end-users featuring pharmaceuticals; referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products in the nature of medical referrals; business administration of prescription drug co-payment programs; business administration of patient reimbursement programs; referral services in the field of co-pay assistance programs in the nature of providing insurance agent referrals; providing an online commercial information directory in the field of patient support featuring information regarding healthcare providers, sites at which subcutaneous injections could be administered and retail pharmacies or specialty pharmacies where patients could obtain pharmaceutical preparations |
| Goods and Services | Patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; providing patient support services relating to cancer and cancer treatment in the nature of an Internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information about bone health in patients with cancer by offering customized medical information and practical advice for communicating about bone health with healthcare providers; information services, namely, providing medical consultancy and advisory services via a global computer network in the field of cancer-related bone health; providing medical information and patient support services, namely, providing pharmaceutical advice and consultation in the nature of providing online information regarding bone health, the prevention of osteoporosis and the treatment and management of osteoporosis and bone disease, and pharmaceutical preparations for the treatment of osteoporosis; medical report services in the nature of providing medical reports regarding patients being treated for osteoporosis and bone disease; providing medical consultancy and advisory services via a global computer network in the field of cancer treatment and chemotherapy; providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding immune thrombocytopenic purpura; providing health and medical information about immune thrombocytopenic purpura; information services, namely, providing medical information to immune thrombocytopenic purpura patients; patient support services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel |
| Goods and Services | Drug delivery devices in the nature of drug delivery systems; drug delivery systems; injection device for pharmaceutical preparations; injectors for medical purposes in the nature of medical fluid injectors |
| Goods and Services | Pharmaceutical research and development services; biological research; chemical research; medical research, namely, conducting clinical trials for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, January 1, 1990 |
| First Use In Commerce Date | Monday, January 1, 1990 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 010 |
| First Use Anywhere Date | Monday, January 1, 2007 |
| First Use In Commerce Date | Monday, January 1, 2007 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, January 1, 2010 |
| First Use In Commerce Date | Friday, January 1, 2010 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 21, 2016 |
| Primary Code | 036 |
| First Use Anywhere Date | Thursday, January 1, 2015 |
| First Use In Commerce Date | Thursday, January 1, 2015 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 041 |
| First Use Anywhere Date | Friday, January 1, 2010 |
| First Use In Commerce Date | Friday, January 1, 2010 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, January 1, 1990 |
| First Use In Commerce Date | Monday, January 1, 1990 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 4, 2015 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, January 1, 2010 |
| First Use In Commerce Date | Friday, January 1, 2010 |
| Party Name | Amgen Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 91320-1799 |
| Party Name | Amgen Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 913201799 |
| Party Name | Amgen Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 913201799 |
| Event Date | Event Description |
| Friday, January 8, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 3, 2015 | NEW APPLICATION ENTERED |
| Friday, December 4, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 7, 2016 | ASSIGNED TO EXAMINER |
| Friday, January 8, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, January 8, 2016 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 13, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 20, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 20, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 21, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 11, 2016 | FINAL REFUSAL WRITTEN |
| Wednesday, May 11, 2016 | FINAL REFUSAL E-MAILED |
| Wednesday, May 11, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, July 13, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 13, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 13, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 29, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 31, 2017 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 14, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 27, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 16, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 16, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 11, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 27, 2017 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 27, 2017 | SOU EXTENSION 1 FILED |
| Monday, March 27, 2017 | SOU EXTENSION 1 GRANTED |
| Tuesday, September 12, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 2, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 31, 2017 | SOU EXTENSION 2 FILED |
| Tuesday, September 12, 2017 | SOU EXTENSION 2 GRANTED |
| Wednesday, September 13, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 13, 2018 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 13, 2018 | SOU EXTENSION 3 FILED |
| Thursday, March 15, 2018 | SOU EXTENSION 3 GRANTED |
| Friday, March 16, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 2, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 11, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 28, 2019 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 7, 2018 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 7, 2018 | SOU EXTENSION 4 FILED |
| Friday, September 7, 2018 | SOU EXTENSION 4 GRANTED |
| Thursday, March 7, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, March 7, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 3, 2019 | SOU EXTENSION 5 GRANTED |
| Thursday, April 4, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 28, 2019 | SOU EXTENSION 5 FILED |
| Thursday, October 10, 2019 | USE AMENDMENT FILED |
| Saturday, October 12, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, April 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Monday, October 28, 2019 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, October 28, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, October 28, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 14, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, May 15, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, June 16, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Friday, April 29, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, April 29, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 29, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, April 29, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, April 29, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, April 29, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 25, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, February 25, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 25, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 25, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, February 25, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 16, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |